Endovascular repair of type B aortic dissection: long-term results of the randomized investigation of stent grafts in aortic dissection trial
- PMID: 23922146
- DOI: 10.1161/CIRCINTERVENTIONS.113.000463
Endovascular repair of type B aortic dissection: long-term results of the randomized investigation of stent grafts in aortic dissection trial
Abstract
Background: Thoracic endovascular aortic repair (TEVAR) represents a therapeutic concept for type B aortic dissection. Long-term outcomes and morphology after TEVAR for uncomplicated dissection are unknown.
Methods and results: A total of 140 patients with stable type B aortic dissection previously randomized to optimal medical treatment and TEVAR (n=72) versus optimal medical treatment alone (n=68) were analyzed retrospectively for aorta-specific, all-cause outcomes, and disease progression using landmark statistical analysis of years 2 to 5 after index procedure. Cox regression was used to compare outcomes between groups; all analyses are based on intention to treat. The risk of all-cause mortality (11.1% versus 19.3%; P=0.13), aorta-specific mortality (6.9% versus 19.3%; P=0.04), and progression (27.0% versus 46.1%; P=0.04) after 5 years was lower with TEVAR than with optimal medical treatment alone. Landmark analysis suggested a benefit of TEVAR for all end points between 2 and 5 years; for example, for all-cause mortality (0% versus 16.9%; P=0.0003), aorta-specific mortality (0% versus 16.9%; P=0.0005), and for progression (4.1% versus 28.1%; P=0.004); Landmarking at 1 year and 1 month revealed consistent findings. Both improved survival and less progression of disease at 5 years after elective TEVAR were associated with stent graft induced false lumen thrombosis in 90.6% of cases (P<0.0001).
Conclusions: In this study of survivors of type B aortic dissection, TEVAR in addition to optimal medical treatment is associated with improved 5-year aorta-specific survival and delayed disease progression. In stable type B dissection with suitable anatomy, preemptive TEVAR should be considered to improve late outcome.
Clinical trial registration url: http://www.clinicaltrials.gov. Unique identifier: NCT01415804.
Keywords: aortic dissection; aortic remodeling; prognosis; stent graft.
Comment in
-
Thoracic endovascular aortic repair for type B dissection: a ubiquitous treatment option?Circ Cardiovasc Interv. 2013 Aug;6(4):326-8. doi: 10.1161/CIRCINTERVENTIONS.113.000643. Circ Cardiovasc Interv. 2013. PMID: 23963578 No abstract available.
Similar articles
-
Randomized comparison of strategies for type B aortic dissection: the INvestigation of STEnt Grafts in Aortic Dissection (INSTEAD) trial.Circulation. 2009 Dec 22;120(25):2519-28. doi: 10.1161/CIRCULATIONAHA.109.886408. Epub 2009 Dec 7. Circulation. 2009. PMID: 19996018 Clinical Trial.
-
Volume analysis of true and false lumens in acute complicated type B aortic dissections after thoracic endovascular aortic repair with stent grafts alone or with a composite device design.J Vasc Surg. 2016 May;63(5):1216-24. doi: 10.1016/j.jvs.2015.11.037. Epub 2016 Jan 22. J Vasc Surg. 2016. PMID: 26806523
-
Improved Remodeling With TEVAR and Distal Bare-Metal Stent in Acute Complicated Type B Dissection.Ann Thorac Surg. 2020 Nov;110(5):1572-1579. doi: 10.1016/j.athoracsur.2020.02.029. Epub 2020 Mar 20. Ann Thorac Surg. 2020. PMID: 32205112
-
Influence and critique of the INSTEAD Trial (TEVAR versus medical treatment for uncomplicated type B aortic dissection).Semin Vasc Surg. 2011 Sep;24(3):167-71. doi: 10.1053/j.semvascsurg.2011.10.003. Semin Vasc Surg. 2011. PMID: 22153028 Review.
-
Treatment of uncomplicated type B aortic dissection.Gen Thorac Cardiovasc Surg. 2017 Feb;65(2):74-79. doi: 10.1007/s11748-016-0734-0. Epub 2016 Dec 5. Gen Thorac Cardiovasc Surg. 2017. PMID: 27921203 Review.
Cited by
-
Narrow true lumen favors future complication even in small diameter of type B aortic dissection.J Thorac Dis. 2024 Oct 31;16(10):6357-6367. doi: 10.21037/jtd-24-864. Epub 2024 Oct 25. J Thorac Dis. 2024. PMID: 39552903 Free PMC article.
-
Trends in utilization, timing, and outcomes of thoracic endovascular repair for type B aortic dissection in the United States.JTCVS Open. 2024 Jul 29;21:35-44. doi: 10.1016/j.xjon.2024.07.016. eCollection 2024 Oct. JTCVS Open. 2024. PMID: 39534356 Free PMC article.
-
Safe and favorable prognosis of thoracic endovascular aortic repair for the low-risk patients with non-acute type B aortic dissection.Front Cardiovasc Med. 2024 Oct 28;11:1442800. doi: 10.3389/fcvm.2024.1442800. eCollection 2024. Front Cardiovasc Med. 2024. PMID: 39529972 Free PMC article.
-
Long-Term Outcomes of Endovascular Repair of Thoracic Aortic Aneurysms.Int J Angiol. 2024 May 30;33(4):237-249. doi: 10.1055/s-0044-1787304. eCollection 2024 Dec. Int J Angiol. 2024. PMID: 39502344 Review.
-
Type B Aortic Dissection Management: A Narrative Review of Guidelines and Systematic Reviews.Galen Med J. 2023 Dec 18;12:1-9. doi: 10.31661/gmj.v12i.2967. eCollection 2023. Galen Med J. 2023. PMID: 39430041 Free PMC article.
Publication types
MeSH terms
Associated data
LinkOut - more resources
Full Text Sources
Other Literature Sources

